Device Trial Radar · NCT07178314
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
38
Planned (sponsor's estimate)
Start
Oct 6, 2025
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Oregon Health and Science UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- American Urogynecologic Society
- First posted
- Sep 17, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study contains a mixed-methods design consisting of a single-arm, interventional study and prospective patient interviews evaluating a novel self-implemented at-home Transcutaneous Tibial Nerve Stimulation (TTNS) treatment protocol for management of treatment naïve overactive bladder (OAB) among rural-dwelling women. This study will be conducted in 3 rural Oregon communities where Oregon Health \& Science University satellite campuses are located.
Conditions
- Overactive Bladder
Interventions
Transcutaneous Tibial Nerve Stimulation (TTNS)Device
Participants will perform self-implemented at-home transcutaneous tibial nerve stimulation using a transcutaneous electrical nerve stimulation (TENS) unit. Participants will be instructed to use the TENS unit to deliver stimulation to the tibial nerve on one ankle for a 30-minute session, three times per week for 12 weeks upon receipt of the device. Intensity will be based on the participant's tolerance, just above the perception threshold but not painful.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overactive Bladder questionnaire short form (OAB-q SF) Health-related Quality of lifeTime frame: Evaluated upon enrollment and following 12 weeks of intervention
- Overactive Bladder questionnaire short form (OAB-q SF) symptom botherTime frame: Evaluated upon enrollment and following 12 weeks of intervention
- 24-hour voiding frequencyTime frame: 3-day voiding diary completed upon enrollment and following 12 weeks of intervention
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Oregon Health & Science University
Portland, Oregon · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.